American Portfolios Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

American Portfolios Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$6.83K	Hold	4,350	–	–	﹤0.01%	2685
2022 Q2	$8.74K	Hold	4,350	–	–	﹤0.01%	2619
2022 Q1	$10.1K	Buy	4,350 +1,500	+53%	+$4.68K	﹤0.01%	2678
2021 Q4	$13.3K	Hold	2,850	–	–	﹤0.01%	2513
2021 Q3	$21.7K	Hold	2,850	–	–	﹤0.01%	2248
2021 Q2	$27.6K	Sell	2,850 -2,000	-41%	-$15.9K	﹤0.01%	2049
2021 Q1	$40.1K	Sell	4,850 -800	-14%	-$8.45K	﹤0.01%	1703
2020 Q4	$38.6K	Sell	5,650 -1,725	-23%	-$13.9K	﹤0.01%	1521
2020 Q3	$82.2K	Buy	7,375 +1,950	+36%	+$17.8K	﹤0.01%	1137
2020 Q2	$34.1K	Buy	+5,425	New	+$20.8K	﹤0.01%	1428
2019 Q1	–	Sell	-500	Closed	-$1.2K	–	2665
2018 Q4	$1.2K	Sell	500 -1,000	-67%	-$3.27K	﹤0.01%	2231
2018 Q3	$6.6K	Hold	1,500	–	–	﹤0.01%	1906
2018 Q2	$10.8K	Hold	1,500	–	–	﹤0.01%	1694
2018 Q1	$7.72K	Sell	1,500 -500	-25%	-$3.56K	﹤0.01%	1724
2017 Q4	$7.6K	Buy	+2,000	New	+$5.21K	﹤0.01%	1656

Other funds holding SRNE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

American Portfolios Advisors's SRNE Position: Q3 2022 in Review

American Portfolios Advisors held its Sorrento Therapeutics, Inc. (SRNE) position steady in Q3 2022 at 4,350 shares worth $6.83K. The position accounts for ﹤0.01% of the portfolio, ranked #2685.

American Portfolios Advisors first reported a position in SRNE in Q4 2017 and has held it in 15 quarters since. The position peaked at $82.2K in Q3 2020. 233 funds tracked by Wall St. Rank hold SRNE as of Q3 2022.

American Portfolios Advisors held 4,350 shares of Sorrento Therapeutics, Inc. worth $6.83K as of Q3 2022.
American Portfolios Advisors left its Sorrento Therapeutics, Inc. share count unchanged in Q3 2022.
Sorrento Therapeutics, Inc. made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2685 holding.
American Portfolios Advisors first reported a position in Sorrento Therapeutics, Inc. in Q4 2017 and has held it in 15 quarters since.
American Portfolios Advisors's Sorrento Therapeutics, Inc. position peaked at $82.2K in Q3 2020.
233 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.